Elite HRT Certification (EHRT-C) — Questions and Answers

Question 1: Active liver disease is a relative or absolute contraindication to HRT primarily because the liver is responsible for what?

Producing ovarian hormones
Regulating FSH and LH secretion
Metabolizing and clearing exogenous hormones (Correct answer)
Absorbing hormones from the GI tract

Correct answer: Metabolizing and clearing exogenous hormones

The liver metabolizes sex hormones; active liver disease impairs this clearance, leading to hormone accumulation and increased side effects.

Question 2: What is the primary quality concern with compounded hormone preparations that the FDA has identified?

Compounded hormones can only be legally dispensed in cream form
Lack of mandatory pre-market testing for potency, sterility, and consistency (Correct answer)
Compounded products are always stronger than commercial equivalents
State pharmacies are prohibited from compounding more than 10 hormone products

Correct answer: Lack of mandatory pre-market testing for potency, sterility, and consistency

Because compounded preparations are not subject to the same FDA pre-market testing as commercial drugs, there are ongoing concerns about consistency in potency, sterility, and overall quality control.

Question 3: A patient on oral estrogen therapy develops elevated triglycerides. What delivery method change should be considered?

Increase oral estrogen dose
Switch to transdermal estrogen (Correct answer)
Add a statin and continue orals
Switch to intramuscular progesterone

Correct answer: Switch to transdermal estrogen

Transdermal estrogen avoids hepatic first-pass metabolism, which is responsible for the triglyceride elevation seen with oral estrogen.

Question 4: Intramuscular testosterone cypionate injections are typically administered at what interval for male HRT?

Monthly
Every 1–2 weeks (Correct answer)
Every 6 months
Daily

Correct answer: Every 1–2 weeks

Testosterone cypionate has a half-life that makes every 1–2 week IM injections the standard dosing interval for steady hormone levels.

Question 5: Why are estradiol levels monitored in hormone replacement therapy?

To check testosterone suppression
To evaluate estrogen balance (Correct answer)
To prevent osteoporosis only
To regulate mood

Correct answer: To evaluate estrogen balance

Estradiol is the most potent form of estrogen and plays a central role in female reproductive health. Monitoring estradiol levels during HRT is essential to ensure that the patient is receiving an proper dose, preventing symptoms of both estrogen deficiency and excess. This helps achieve optimal therapeutic effects while minimizing potential side effects.

Question 6: What is the primary criticism major medical organizations such as ACOG raise about compounded bioidentical HRT?

Lack of long-term safety and efficacy data from large randomized controlled trials (Correct answer)
There are no FDA-approved bioidentical hormone preparations available
Bioidentical hormones cannot be absorbed transdermally
Bioidentical hormones are universally too expensive for patients

Correct answer: Lack of long-term safety and efficacy data from large randomized controlled trials

Major medical organizations criticize compounded BHRT primarily because it lacks the large randomized controlled trial data that FDA-approved HRT products must demonstrate to establish long-term safety and efficacy.

Question 7: What is the primary advantage most often cited for compounded bioidentical HRT over standard commercial preparations?

Lower cost guaranteed by federal compounding regulations
Customizable dosing tailored to individual patient needs (Correct answer)
Longer shelf life than commercially manufactured products
Complete absence of side effects compared to commercial HRT

Correct answer: Customizable dosing tailored to individual patient needs

The principal advantage of compounded BHRT is the ability to customize hormone doses, combinations, and delivery forms to meet each patient's specific requirements.

Question 8: Why is a DHEA-S test ordered in hormone evaluations?

It evaluates bone density
It assesses adrenal androgen production (Correct answer)
It measures estrogen levels
It monitors thyroid function

Correct answer: It assesses adrenal androgen production

DHEA-S (Dehydroepiandrosterone sulfate) is an androgen primarily produced by the adrenal glands. Measuring DHEA-S levels helps evaluate adrenal function and identify conditions related to excess or deficiency of adrenal androgens. This test is crucial in hormone evaluations to distinguish adrenal androgen issues from gonadal ones, impacting overall hormone balance.

Question 9: What does a low serum testosterone level in males typically indicate?

Adrenal insufficiency
High estrogen
Hypogonadism (Correct answer)
Thyroid overactivity

Correct answer: Hypogonadism

A low serum testosterone level in males is the hallmark diagnostic criterion for hypogonadism. This condition indicates that the testes are not producing adequate amounts of testosterone, leading to various symptoms such as reduced libido, fatigue, and muscle loss. Therefore, a low testosterone level directly points to hypogonadism.

Question 10: Which hormone regulates the body’s metabolic rate?

Thyroxine (T4) (Correct answer)
Testosterone
Insulin
Cortisol

Correct answer: Thyroxine (T4)

Thyroxine (T4) is the main hormone produced by the thyroid gland, and it plays a critical role in regulating the body's metabolic rate. T4 influences nearly every cell in the body, affecting energy production, body temperature, heart rate, and digestion. Proper thyroid function is essential for maintaining overall metabolic health.

Question 11: Which hormone is commonly assessed to determine menopause status?

FSH (Correct answer)
Insulin
DHEA
Cortisol

Correct answer: FSH

Follicle-stimulating hormone (FSH) levels are commonly assessed to determine menopause status. As ovarian function declines during perimenopause and menopause, estrogen production decreases, leading to a compensatory rise in FSH levels. Persistently elevated FSH levels, along with clinical symptoms, are indicative of menopause.

Question 12: What is a common side effect of oral estrogen therapy that should be monitored?

Dry mouth
Blurred vision
Thromboembolism (Correct answer)
Constipation

Correct answer: Thromboembolism

Oral estrogen therapy is associated with an increased risk of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism. This is because oral estrogen undergoes first-pass metabolism in the liver, which can affect the production of clotting factors. This risk is a significant safety concern that requires careful patient selection and monitoring.

Question 13: How often should bone mineral density be assessed in postmenopausal women on long-term HRT?

Every 3–5 years
Every 1–2 years (Correct answer)
Only at the start of therapy
Every 6 months

Correct answer: Every 1–2 years

Bone mineral density (BMD) should be assessed periodically in postmenopausal women on long-term HRT to monitor its effectiveness in preventing osteoporosis. While HRT can help maintain bone density, regular checks, typically every 1-2 years, are recommended. This frequency helps ensure the therapy is achieving its desired effect and guides treatment decisions.

Question 14: Testosterone pellet insertion is performed in which anatomical location?

Antecubital fossa
Intra-abdominal cavity
Deltoid muscle
Upper buttock or hip subcutaneous tissue (Correct answer)

Correct answer: Upper buttock or hip subcutaneous tissue

Testosterone pellets are inserted into the subcutaneous fat of the upper buttock or hip via a small trocar incision under local anesthesia.

Question 15: Which test would be used to evaluate cortisol rhythm in suspected adrenal disorders?

Fasting glucose
24-hour salivary cortisol (Correct answer)
Lipid panel
TSH

Correct answer: 24-hour salivary cortisol

Cortisol levels fluctuate throughout the day, following a diurnal rhythm. A 24-hour salivary cortisol test allows for multiple samples to be collected at different times, providing a comprehensive profile of cortisol production and its rhythm. This method is ideal for evaluating suspected adrenal disorders like Cushing's syndrome or adrenal insufficiency, where the normal rhythm is disrupted.

Question 16: Under which section of the Federal Food, Drug, and Cosmetic Act is traditional pharmacy compounding regulated?

Section 501B
Section 503A (Correct answer)
Section 404C
Section 602D

Correct answer: Section 503A

Section 503A of the FD&C Act governs traditional pharmacy compounding, exempting qualifying pharmacies from certain FDA requirements when compounding pursuant to a valid individual patient prescription.

Question 17: How often should patients on HRT be monitored for hormone levels?

Once a year
Every 3–6 months (Correct answer)
Every week
Never needed

Correct answer: Every 3–6 months

Regular monitoring of hormone levels is crucial for patients on HRT to ensure therapeutic efficacy and safety. Once stable, monitoring every 3-6 months allows clinicians to assess hormone levels, evaluate symptom control, and detect potential side effects or imbalances. This frequency helps maintain optimal treatment while minimizing patient burden.

Question 18: What is the recommended rotation practice for transdermal estrogen patches to minimize skin irritation?

Apply only to the abdomen
Always apply to the same site
Change site monthly
Rotate sites with each patch change (Correct answer)

Correct answer: Rotate sites with each patch change

Rotating the application site with each patch change prevents skin irritation, contact sensitization, and poor adhesion from repeated use at the same spot.

Question 19: Transfer of testosterone topical gel to children or female partners is a well-documented safety concern. What is the primary recommended prevention measure?

Allow gel to dry completely and cover application site before skin contact with others (Correct answer)
Inform partners verbally without other precautions
Apply gel only to the scalp
Wash hands only

Correct answer: Allow gel to dry completely and cover application site before skin contact with others

Allowing the gel to dry fully and covering the application site prevents accidental transfer of testosterone to children or female partners who may experience virilization.

Question 20: When prescribing compounded HRT, a practitioner's documentation should include which element to satisfy medical necessity requirements?

A note stating the patient preferred compounded products
Documentation of why an FDA-approved product is inadequate for the patient's specific clinical need (Correct answer)
Pharmacy's convenience as the reason
Price comparison to FDA products

Correct answer: Documentation of why an FDA-approved product is inadequate for the patient's specific clinical need

Prescribing compounded HRT requires documenting clinical justification for why commercially available FDA-approved products cannot meet the patient's individualized need.

Question 21: Why should testosterone levels be measured in the morning for male HRT evaluation?

Morning samples avoid dietary interference
Labs only process samples in the morning
Afternoon samples require a different reference range
Testosterone follows a diurnal rhythm, peaking in the morning and declining throughout the day (Correct answer)

Correct answer: Testosterone follows a diurnal rhythm, peaking in the morning and declining throughout the day

Testosterone secretion follows a circadian pattern, with peak levels occurring in the morning (6–10 AM); afternoon draws may yield falsely low results.

Question 22: According to the Menopause Society (NAMS) guidelines, what is the recommended minimum effective dose principle for menopausal HRT?

Use standard fixed doses regardless of patient response
Use the lowest effective dose for the shortest duration consistent with treatment goals (Correct answer)
Use the highest tolerated dose for maximum benefit
Dose based only on body weight

Correct answer: Use the lowest effective dose for the shortest duration consistent with treatment goals

NAMS recommends individualized dosing using the lowest effective dose for the shortest duration needed to achieve symptom control and therapeutic goals.

Question 23: Which lab test is commonly used to assess thyroid function?

FSH
Prolactin
LH
TSH (Correct answer)

Correct answer: TSH

A TSH (Thyroid-Stimulating Hormone) test is the most common and sensitive initial lab test used to assess thyroid function. TSH levels indicate how well the pituitary gland is communicating with the thyroid. High TSH often suggests an underactive thyroid (hypothyroidism), while low TSH can indicate an overactive thyroid (hyperthyroidism).

Question 24: Vaginal estrogen creams are applied locally to treat which condition while minimizing systemic estrogen exposure?

Osteoporosis
Mood disturbances
Hot flashes
Genitourinary syndrome of menopause (GSM) (Correct answer)

Correct answer: Genitourinary syndrome of menopause (GSM)

Low-dose vaginal estrogen primarily treats GSM symptoms such as vaginal dryness, dyspareunia, and urinary urgency with minimal systemic absorption.

Question 25: What distinguishes bioidentical hormones from synthetic hormones?

They are derived exclusively from plant sources without laboratory modification
They are more potent than synthetic hormone preparations
They are only available through FDA-approved commercial products
They have the same molecular structure as hormones produced by the human body (Correct answer)

Correct answer: They have the same molecular structure as hormones produced by the human body

Bioidentical hormones are chemically identical in molecular structure to the hormones naturally produced by the human body, unlike synthetic hormones which may differ structurally.

Question 26: Which patient history detail would be a contraindication for estrogen replacement therapy?

Mild anxiety
Family history of diabetes
High cholesterol
History of breast cancer (Correct answer)

Correct answer: History of breast cancer

A history of breast cancer is a strong contraindication for estrogen replacement therapy. Estrogen can stimulate the growth of certain types of breast cancer cells, potentially leading to recurrence or progression of the disease. Therefore, HRT containing estrogen is generally avoided in individuals with a personal history of breast cancer.

Question 27: A practitioner conducts a telehealth consultation and prescribes compounded testosterone without an in-person physical exam. What federal exception made this more widely permissible during and after COVID-19?

AMA guidelines allowing any telehealth prescribing
A permanent FDA rule removing all exam requirements
DEA's telemedicine flexibilities and the Ryan Haight Act exception for registered providers during public health emergencies (Correct answer)
State-level OTC reclassification of testosterone

Correct answer: DEA's telemedicine flexibilities and the Ryan Haight Act exception for registered providers during public health emergencies

The DEA issued telemedicine prescribing flexibilities under a public health emergency declaration, temporarily allowing Schedule III prescriptions via telehealth without a prior in-person exam.

Question 28: Which symptom may indicate estrogen overdose in patients undergoing HRT?

Dry eyes
Nausea (Correct answer)
Muscle cramps
Increased hunger

Correct answer: Nausea

Nausea is a common symptom that can indicate estrogen overdose or excessively high estrogen levels in patients undergoing HRT. Other symptoms might include breast tenderness, bloating, or headaches. Monitoring for such symptoms helps clinicians adjust the estrogen dose to achieve optimal therapeutic levels without adverse effects.

Question 29: Which lab value should be monitored to detect polycythemia in patients on testosterone therapy?

FSH
TSH
Calcium
Hematocrit (Correct answer)

Correct answer: Hematocrit

Polycythemia, a common side effect of testosterone therapy, is characterized by an increase in red blood cell mass. Hematocrit, which measures the percentage of red blood cells in the blood, is the primary lab value monitored to detect and assess the severity of polycythemia. Elevated hematocrit levels warrant dose adjustment or cessation of testosterone therapy to reduce cardiovascular risks.

Question 30: For a patient who cannot tolerate oral progesterone due to sedation, which alternative route minimizes CNS side effects?

Higher-dose oral progesterone
Vaginal progesterone (Correct answer)
Intranasal progesterone
Intramuscular estrogen

Correct answer: Vaginal progesterone

Vaginal progesterone achieves high uterine levels with lower systemic absorption, significantly reducing the sedative CNS effects associated with oral use.

Question 31: What is an important safety consideration when prescribing HRT for patients with cardiovascular disease?

Prescribe without screening
Evaluate cardiovascular risk (Correct answer)
Recommend only high-dose patches
Use oral estrogen exclusively

Correct answer: Evaluate cardiovascular risk

When prescribing HRT for patients with cardiovascular disease, it is crucial to thoroughly evaluate their individual cardiovascular risk. HRT, particularly oral estrogen, can influence cardiovascular events, and the risks and benefits must be carefully weighed. This involves assessing factors like age, existing conditions, and the type of HRT to ensure patient safety.

Elite HRT Certification (EHRT-C)

The EHRT-C credential validates competency in hormone replacement therapy for nurse practitioners, covering women's and men's hormonal health, bioidentical hormones, compounding, safety monitoring, contraindications, and delivery methods.

Questions

35 min

Time Limit

80%

To Pass

Checking for saved progress...

Exam Rules

You can skip questions and return to them later
Flag questions for review before submitting
No feedback shown until you submit the entire exam
Unanswered questions count as wrong — answer everything
10 pretest questions are mixed in and don't affect your score
Timer auto-submits when time runs out
Your progress is auto-saved every 30 seconds